Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000008

CEO bought 46,000 shares at an average $0.03 ($1,188)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Collier Alan Brian CEO 2019-01-30 Purchase +5,000 $0.03 $131 21,057,623 D: show line 1 in the form
Collier Alan Brian CEO 2019-01-30 Purchase +5,000 $0.03 $130 21,062,623 D: show line 2 in the form
Collier Alan Brian CEO 2019-01-30 Purchase +5,000 $0.03 $127 21,067,623 D: show line 3 in the form
Collier Alan Brian CEO 2019-01-30 Purchase +5,000 $0.03 $127 21,072,623 D: show line 4 in the form
Collier Alan Brian CEO 2019-01-30 Purchase +5,000 $0.03 $130 21,077,623 D: show line 5 in the form
Collier Alan Brian CEO 2019-01-30 Purchase +5,000 $0.03 $130 21,082,623 D: show line 6 in the form
Collier Alan Brian CEO 2019-01-31 Purchase +5,000 $0.03 $129 21,087,623 D: show line 7 in the form
Collier Alan Brian CEO 2019-01-31 Purchase +5,000 $0.03 $130 21,087,623 D: show line 8 in the form
Collier Alan Brian CEO 2019-01-31 Purchase +5,000 $0.03 $130 21,092,623 D: show line 9 in the form
Collier Alan Brian CEO 2019-01-31 Purchase +1,000 $0.03 $26 21,093,623 D: show line 10 in the form
Open-market purchases · 46,000 sh · avg $0.03 · $1,188
Loading xslF345X03/primary_doc.xml…